Search results
Olympics: Can Sydney McLaughlin-Levrone, Noah Lyles become the Faces of Track & Field?
The Times-Gazette· 2 hours agoSydney McLaughlin has done to the backstretch should be illegal." I'll never forget that line. It...
7th Pay Commission: Central Govt Employees Likely To Get 3% DA Hike in September - News18
News18· 3 hours ago7th Pay Commission DA Hike: Central government employees are likely to get a bonanza soon as the...
Infosys Shares Price Fall After IT Giant Slapped With Rs 32,403 Crore GST Demand Notice
Latest India News· 3 hours agoInfosys Shares Price has been impacted after the GST notice sent to IT major by Authorities.
Trifecta looks to raise $240 million for fourth venture debt fund - The Economic Times
The Economic Times· 10 hours agoVenture debt firm Trifecta Capital has launched its fourth fund, aiming to raise up to Rs 2,000...
Alpine hire Oakes as team principal
Mid Day· 10 hours agoAlpine said Oakes, who is British, would be the second-youngest team principal in F1 history. Alpine named 36-year-old Oliver Oakes as its team principal...
Paris Olympics 2024: A comprehensive list of summer sports | Paris Olympics2024 News - Times of...
The Times of India· 17 hours agoThe most awaited athletic event in the world, the 2024 Summer Olympics, finally kicked underway in...
Helmut Marko Hints at Sergio Perez's Red Bull Departure Despite Resistance from F1 Rights Holder
Pinkvilla· 18 hours agoRed Bull will not make any changes over the balance of the 2024 season. Helmut Marko stated that...
From Thoughtfully Designed Travel Luggage To Bodycare That Smells Like Perfume, 12 New Launches From...
NDTV· 22 hours agoNo matter how sweaty you get during the rainy season, having Aqualogica's Refresh+ body mist range...
Alpine Turn To Briton Oliver Oakes As New F1 Team Principal | Formula 1 News
NDTV· 23 hours agoThe 36-year-old Englishman, a former driver currently at the helm of the Hitech GP team competing in...
Buy Tatva Chintan Pharma Chem; target of Rs 1,850: ICICI Securities
CNBC Awaaz· 1 day agoICICI Securities is bullish on Tatva Chintan Pharma Chem has recommended buy rating on the stock with a target price of Rs 1,850 in its research report dated July 25, 2024.